PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Covalently Linked Protein Regulators
mTOR Signaling and Cancer Progression
Interactions Between Signaling Pathways
Negative Regulator Molecules
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Longhui Xie1, Dekun Song2, Zhengsheng Ouyang3
1Department of Hepatobiliary Pancreatic Spleen Surgery, The Central Hospital of Yongzhou, Yongzhou 425000, PR China.
This study reveals that USP27 promotes hepatocellular carcinoma (HCC) growth by enhancing glycolysis. Targeting the CTCF/USP27/PFKFB3 pathway offers a potential new strategy for treating HCC and reducing metastasis.
08:29SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: